Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Biotech ETFs Are the Best Way to Play the Recovering Sector

By Chris Lau, InvestorPlace Contributor

The biotech sector peaked in 2015. While it bounced back from lows, biotech ETFs give investors exposure to the sector as it recovers.

Apple Inc.’s Driverless Car Ambitions Hinge on Software Development

By Chris Lau, InvestorPlace Contributor

Apple Inc.'s (AAPL) self-driving project is not about money. It won't even make money, but it will position the company in building a business outside of smartphones.

Cigna Corporation Stock Is Trading at a Steep Discount

By Chris Lau, InvestorPlace Contributor

CI stock is trading at over 20% below its yearly high, and it's discounted ahead of the Express Scripts deal. Investors will want to consider Cigna's long-term upside when the deal closes.

Nektar Therapeutics Stock Is Risky But Offers Big Reward

By Chris Lau, InvestorPlace Contributor

Nektar Therapeutics pulled back in recent weeks, and that is a good thing. Valuations are stretched, but the upside in NKTR stock is high if management delivers.

Anthem Inc Is Boring, But Profitable

By Chris Lau, InvestorPlace Contributor

ANTM is a boring stock but that does not exclude it from being a great one. After the first quarter results and 2018 outlook, investors should take a look at this company.

Load More